About Richter Gedeon
Richter Gedeon is a company. Richter Gedeon has completed 2 acquisitions, including Finox Biotech and PregLem. Richter Gedeon offers products and services including Cariprazine and Biosimilars.
-
Sectors
Healthcare
-
Phone
Locked
-
Social
Locked
- Legal Name Richter Gedeon Nyrt
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
-
Investments & Acquisitions
Finox Biotech
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Richter Gedeon
Richter Gedeon offers a comprehensive portfolio of products and services, including Cariprazine and Biosimilars.
This drug is used for treating psychiatric conditions and is developed as part of efforts in original research within the pharmaceutical sector.
Biosimilars are produced for treating conditions like osteoporosis and are manufactured through processes that emphasize innovation and therapeutic efficacy.
People of Richter Gedeon
Unlock access to complete
Unlock access to complete
Funding Insights of Richter Gedeon
Detailed funding history for Richter Gedeon
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Richter Gedeon
Richter Gedeon has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Finox Biotech and PregLem.
Investment portfolio details for Richter Gedeon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Fertility products are developed by this Swiss biopharma firm.
|
Locked | Locked | 2007 | Locked | |
|
Innovative drugs for women's reproductive medicine are developed and commercialized.
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Richter Gedeon
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Richter Gedeon
Detailed financials for Richter Gedeon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Richter Gedeon Comparisons
Peer comparison for Richter Gedeon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Richter Gedeon
Detailed competitors of Richter Gedeon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Richter Gedeon
Complete news archive for Richter Gedeon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Richter Gedeon
Richter Gedeon is identified as a Hungarian-based multinational pharmaceutical company that engages in vertically integrated activities, including drug manufacturing, research and development, commerce, and marketing. Original research, womens health, and biotechnology are emphasized to deliver high-value products across various therapeutic areas. A workforce exceeding 1200 in RD positions it as a key player in Central and Eastern Europe, with a history dating back to 1901. Sustainability is addressed through long-term practices and social responsibility, ensuring innovative solutions for patients worldwide while maintaining ethical standards in operations. This approach supports its strategy to become a prominent midpharma entity in Europe.
Richter Gedeon offers Cariprazine and Biosimilars.
Richter Gedeon has made 2 acquisitions, including Finox Biotech, and PregLem.